Integrating traditional Chinese medicine syndromes with clinical variables to predict lower extremity arterial disease in type 2 diabetes
Integration von Syndromen der traditionellen chinesischen Medizin mit klinischen Variablen zur Vorhersage der arteriellen Erkrankung der unteren Extremitäten bei Typ-2-Diabetes
World Journal of Diabetes · 15.11.2026 · 17 (11)
DOI: 10.4239/wjd.125698 ↗Auf einen Blick
Bei 1.018 stationären Patient:innen mit Typ-2-Diabetes war LEAD häufig. Das XGBoost-Modell erzielte in der Validierung die beste Trennschärfe.
Fragestellung
Welche Risikofaktoren für LEAD bei Typ-2-Diabetes lassen sich aus TCM- und westmedizinischen Merkmalen für Vorhersagemodelle nutzen?
Methode
Retrospektive Analyse von 1.018 in einer Endokrinologie stationären Patient:innen; Aufteilung 7:3 in Trainings- und Validierungsset; LASSO, 5 Machine-Learning-Modelle, 10-fache Kreuzvalidierung, DCA.
Ergebnisse
647/1.018 Patient:innen (63,56 %) hatten LEAD. XGBoost: AUC 0,763 (95 %-KI 0,707–0,815), Accuracy 0,712, Sensitivität 0,651, F1-Score 0,743. Weitere AUCs: RF 0,762, LR 0,758, LightGBM 0,754, GBDT 0,744.
Schlussfolgerung der Autor:innen
Das auf TCM- und westmedizinischen Merkmalen basierende XGBoost-Modell war für die frühe Identifikation von LEAD bei T2DM wirksam und unterstützt individuelle Behandlungsstrategien.
Kernaussagen
- LEAD betraf 63,56 % der 1.018 Patient:innen
- XGBoost erreichte die höchste Validierungs-AUC: 0,763
- Acht Prädiktoren wurden aus 26 Kandidaten identifiziert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.11.2026. Verfasst von Ying-Wei Lv und 7 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND Lower extremity arterial disease (LEAD) is common macrovascular complication of type 2 diabetes mellitus (T2DM) that can lead to intermittent claudication, rest pain, and gangrene. Due to its insidious onset, LEAD is frequently diagnosed, missing the optimal window for intervention. Therefore, the construction of an accurate and convenient early risk prediction model is of significant clinical value. AIM To investigate the risk factors for T2DM-associated LEAD and to develop prediction models using machine learning algorithms based on integrated traditional Chinese medicine (TCM) and Western medicine features. METHODS Clinical data of 1018 inpatients with T2DM admitted to the Department of Endocrinology, The First Affiliated Hospital of Anhui University of Chinese Medicine, were retrospectively analyzed. The dataset was randomly divided into a training set (n = 712) and a validation set (n = 306) at a 7:3 ratio. LASSO regression was used for dimensionality reduction to identify core predictors. Five machine learning models, namely, logistic regression, XGBoost, random forest, gradient boosting decision tree (GBDT), and LightGBM, were constructed based on eight predictors: Age ≥ 60 years, hypertension, reduced hemoglobin, reduced red blood cell count, elevated blood urea nitrogen, emaciation, dark tongue, and fatigue. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, and F1 score. Ten-fold cross-validation was performed to assess model stability. A nomogram was constructed based on logistic regression coefficients for individualized risk visualization. Decision curve analysis (DCA) was used to evaluate clinical utility. RESULTS Among the 1018 patients with T2DM, 647 (63.56%) had LEAD. LASSO regression identified eight core predictors from 26 candidate variables (P < 0.05). In the validation set, the XGBoost model achieved the highest AUC of 0.763 (95% confidence interval: 0.707-0.815), with an accuracy of 0.712, sensitivity of 0.651, and F1 score of 0.743. The AUCs of the remaining models were: Random forest (0.762), logistic regression (0.758), LightGBM (0.754), and GBDT (0.744). Ten-fold cross-validation showed mean AUCs of 0.746 ± 0.006 and 0.736 ± 0.043 in the training and validation sets, respectively, with a minimal difference (ΔAUC = 0.010), indicating favourable stability without obvious overfitting. DCA indicated positive clinical benefit for all five models across a wide threshold probability range, significantly outperforming the “treat all” and “treat none” extreme strategies. CONCLUSION The XGBoost model built on dual-dimensional TCM and Western medicine features is effective for the early identification of LEAD in T2DM patients, providing support for individualized treatment strategies.
Zitieren
APA
Lv, Y., Jiang, A., Geng, Y., Hu, M., Wang, Y., Ma, L., Shen, N., & Zhao, J. (2026). Integrating traditional Chinese medicine syndromes with clinical variables to predict lower extremity arterial disease in type 2 diabetes. World Journal of Diabetes, 17(11). https://doi.org/10.4239/wjd.125698
Vancouver
Lv Y, Jiang A, Geng Y, Hu M, Wang Y, Ma L, et al. Integrating traditional Chinese medicine syndromes with clinical variables to predict lower extremity arterial disease in type 2 diabetes. World Journal of Diabetes. 2026;17(11). doi:10.4239/wjd.125698
BibTeX
@article{Lv2026,
author = {Lv, Ying-Wei and Jiang, Ai-Juan and Geng, Yu-Meng and Hu, Min and Wang, Yu-Qing and Ma, Lin and Shen, Nuo and Zhao, Jin-Dong},
title = {Integrating traditional Chinese medicine syndromes with clinical variables to predict lower extremity arterial disease in type 2 diabetes},
journal = {World Journal of Diabetes},
year = {2026},
volume = {17},
number = {11},
doi = {10.4239/wjd.125698}
}
EUVIMED